At the time of writing, Capricor Therapeutics Inc [CAPR] stock is trading at $5.89, up 16.87%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CAPR shares have gain 29.03% over the last week, with a monthly amount glided 50.64%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 6, March 2024, Capricor Therapeutics Presents at 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference. In a post published today on Yahoo Finance, Presentation Highlights Positive 24-Month Results from HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy.
From an analyst’s perspective:
Capricor Therapeutics Inc [NASDAQ: CAPR] stock has seen the most recent analyst activity on January 05, 2024, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $8. Previously, Ladenburg Thalmann started tracking the stock with Buy rating on October 26, 2022, and set its price target to $15. On December 26, 2018, downgrade downgraded it’s rating to Hold. H.C. Wainwright reiterated its Buy rating and increased its price target to $8.60 on January 26, 2018. H.C. Wainwright reiterated its recommendation of a Buy and raised its price target to $6.50 on September 15, 2017.
For the past year, the stock price of Capricor Therapeutics Inc fluctuated between $2.68 and $8.22. Capricor Therapeutics Inc [NASDAQ: CAPR] shares were valued at $5.89 at the most recent close of the market.
Analyzing the CAPR fundamentals
According to Capricor Therapeutics Inc [NASDAQ:CAPR], the company’s sales were 25.18M for trailing twelve months, which represents an 1159.30% jump. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at -0.95%, Pretax Profit Margin comes in at -0.89%, and Net Profit Margin reading is 15.65%. To continue investigating profitability, this company’s Return on Assets is posted at 10.61, Equity is 83.26 and Total Capital is -5.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -1.35.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.28 points at the first support level, and at 4.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.20, and for the 2nd resistance point, it is at 6.50.
Capricor Therapeutics Inc [CAPR] reported earnings per share of -$0.02 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.09/share, meaning a difference of $0.07 and a surprise factor of 77.80%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.25 per share as compared to estimates of -$0.29 per share, a difference of $0.04 representing a surprise of 13.80%.
Ratios To Look Out For
It is important to note that Capricor Therapeutics Inc [NASDAQ:CAPR] has a current ratio of 0.90. In addition, the Quick Ratio stands at 0.90 and the Cash Ratio stands at 0.27. Considering the valuation of this stock, the price to sales ratio is 7.29, the price to book ratio is 8.12.
Transactions by insiders
Recent insider trading involved Musket David B, Director, that happened on Oct 12 ’23 when 410.0 shares were purchased. Director, COLLIER EARL M JR completed a deal on Oct 10 ’23 to buy 10000.0 shares. Meanwhile, Director Musket David B bought 5083.0 shares on Oct 09 ’23.
